TipRanks
55% OFF
PC:DUALI

Dualitas Therapeutics Inc

Dualitas Therapeutics Inc. is a biotechnology company focused on developing next-generation bispecific antibody therapies for immunology and inflammation. Utilizing its proprietary DualScreen™ discovery engine, Dualitas is advancing a portfolio that includes lead programs DTX-103 for allergic diseases and DTX-102 for autoimmune diseases. The company aims to address unmet medical needs by leveraging novel cell-surface proximity mechanisms and strategic collaborations to enhance the therapeutic potential of its bispecific antibodies.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$65M
Total Funding Rounds
1
Latest Funding Amount
$65M
Latest Funding Round
Series A
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 16, 2025Series A$65.00M―

Similar Companies

A snapshot of private companies similar to Dualitas Therapeutics Inc, helping you discover and navigate related company profiles.

Related News and Analysis